aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810 Inhibits Tumor Growth and Therapy Resistance in Highly Aggressive Cancers at the 2023 AACR Annual Meeting

Author's Avatar
Apr 17, 2023

Findings demonstrate effects of ATYR2810 in models of certain forms of lung and kidney cancers